FIELD: medicine.;SUBSTANCE: invention describes method of estimating severity of course of hemorrhagic fever with renal syndrome, which includes determination of marker of vessel endothelium dysfunction in blood, where in blood plasma as marker of vessel endothelium dysfunction determined is concentration of antigen of inhibitor of plasminogen 1 type (IAP-1) activators in febrile period of disease and value of IAP-1 antigen concentration from 341.2 to 570.0 ng/ml is estimated as predictor of moderate form of disease, from 240.0 to 320.1 ng/ml - as predictor of severe form of disease without complications, from 138.3 to 75.5 ng/ml value is estimated as predictor of severe form of disease with complicated course.;EFFECT: invention makes it possible to estimate severity of HFRS course in order to predict in the earliest terms development of disease complications.;1 tbl, 3 ex
展开▼
机译:发明领域本发明描述了估计肾综合征出血热病程的严重性的方法,其包括确定血液中血管内皮功能障碍的标志物,其中血浆中作为血管内皮功能障碍标志物的确定是抗原的浓度。估计在疾病高热期发生纤溶酶原1型激活剂(IAP-1)的抑制剂和IAP-1抗原浓度从341.2至570.0 ng / ml的值可作为中度疾病的预测指标,从240.0至320.1 ng / ml-如没有并发症的严重疾病形式的预测因子,估计为138.3至75.5 ng / ml值,是具有复杂病程的严重疾病形式的预测因子。效果:本发明可以估算HFRS病程的严重性,以便尽早预测疾病并发症的发生。1tbl,3 ex
展开▼